Online Program

322552
Understanding the reasons why Medicare beneficiaries voluntarily disenroll from Medicare Advantage and Part D Drug Plans: Findings from a national patient experience survey


Wednesday, November 4, 2015 : 11:10 a.m. - 11:30 a.m.

Cheryl Damberg, RAND Corporation, Santa Monica, CA
Nate Orr, MA, RAND Corporation, Santa Monica, CA
Steven Martino, PhD, RAND Corporation, Pittsburgh, PA
Alan M. Zaslavsky, PhD, Department of Health Care Policy, Harvard Medical School, Boston, MA
Brett Ewing, MS, RAND Corporation, Santa Monica, CA
Marissa Silverman, MSPH, RAND Corporation, Santa Monica, CA
Marc N. Elliott, PhD, RAND Corporation, Santa Monica, CA
Surveys of health plan disenrollees can be used to improve the quality of care and services. This study sought to understand the reasons why Medicare beneficiaries disenrolled from their Medicare Advantage Plans (MA) and Prescription Drug Plans (PDP) and to explore variations by beneficiary characteristics (race/ethnicity, dual-eligibility status), type of plan, and region.

A random sample of disenrollees from MA and PDP plans were surveyed as part of CMS’s 2013 Medicare PDP and MA plan disenrollment survey (N= 55,341 completes). Five composite measures of reasons for voluntary disenrollment (financial, prescription drug benefits and coverage, health plan patient experience, prescription drug patient experience, and coverage of doctors and hospitals) were constructed using multilevel confirmatory factor analysis. We calculated composite scores for contracts, beneficiaries, and subgroups of beneficiaries, using effect sizes to characterize variation across regions and subgroups. Results were adjusted for age, education, self-reported general and mental health status, state, low-income subsidy, dual eligibility, and proxy assistance.

MA disenrollees endorsed financial reasons (27.7% of items endorsed) and reasons related to coverage of doctors and hospitals (22.5%) most frequently—overall and in each of the nine census divisions— with plan patient experience (13.6%), prescription drug patient experience (9.5%), and prescription benefits and coverage (8.3%) less frequently endorsed. Regional variation was greatest among MA disenrollees for patient experience with plans. Financial reasons were also most commonly endorsed in all regions for PDP disenrollees (41.5% of composite items endorsed overall; less regional variation compared to MA disenrollees). Benefits and coverage was the next most commonly endorsed reason (13.0% of composite items) for PDP disenrollees. The largest effect sizes were observed by region for all reasons for both contract types. Among MA disenrollees, non-Hispanic Whites endorsed financial reasons more often (29.4%) than Asian Pacific Islanders (24.7%), Hispanics (23.9%), and African Americans (23.1%), but minority beneficiaries cited more total reasons for disenrollment than non-Hispanic Whites (similar pattern for PDP disenrollees). All correlations of financial reasons with other reasons are significantly negative, with the largest correlations being -0.6/-0.5 in MA/PDP.

Educational efforts to better convey the benefits and coverage and likely costs of Medicare plans may further improve beneficiaries initial plan choices.  Disenrollee surveys fill gaps in data collected by surveys of continuing enrollees. These results can be used by MA and PDP plans to improve quality and to reduce disenrollment, by CMS to monitor contract performance, and by Medicare beneficiaries to select plans and coverage.

Learning Areas:

Public health or related public policy
Public health or related research

Learning Objectives:
Discuss variation in reasons cited for voluntary disenrollment from Medicare Advantage and Part D plans by region, patient characteristics, and coverage type. Explain how beneficiaries, plans, and CMS might use disenrollment reasons survey data to make informed choices, improve quality, and reduce disenrollment.

Keyword(s): Medicare, Patient Satisfaction

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I hold the RAND Distinguished Chair in Health Care Payment Policy and have more than 25 years of experience in health economics, quality measurement and reporting, and the use of financial incentives to improve cost and quality. My areas of expertise include pay for performance and value-based purchasing applications of performance measures, physician and hospital performance measurement, measures of cost-efficiency/resource use, and evaluating the effects of performance measurement systems and alternative payment models.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.